Search Results - "CHATTINGTON, P. D"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats

    The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats by WALKER, A. B, CHATTINGTON, P. D, BUCKINGHAM, R. E, WILLIAMS, G

    Published in Diabetes (New York, N.Y.) (01-07-1999)
    “…The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. A B Walker…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro

    Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro by WALKER, A. B, NADERALI, E. K, CHATTINGTON, P. D, BUCKINGHAM, R. E, WILLIAMS, G

    Published in Diabetes (New York, N.Y.) (01-05-1998)
    “…Differential vasoactive effects of the insulin sensitizers rosiglitazone (BRL 49653) and troglitazone on human small arteries in vitro. A B Walker , E K…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Partial hypopituitarism and Langerhans cell histiocytosis

    Partial hypopituitarism and Langerhans cell histiocytosis by Balaguruswamy, S, Chattington, P D

    Published in BMJ case reports (2011)
    “…A case of multisystem Langerhans cell histiocytosis with pituitary involvement nearly 20 years after initial presentation. A 48-year-old man had histiocytosis…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Atrial natriuretic peptide in Type 2 diabetes mellitus: response to a physiological mixed meal and relationship to renal function

    Atrial natriuretic peptide in Type 2 diabetes mellitus: response to a physiological mixed meal and relationship to renal function by Chattington, P.D., Anderson, J.V., Rees, L.H., Leese, G.P., Peters, J.R., Vora, J.P.

    Published in Diabetic medicine (01-05-1998)
    “…Relatively few data exist on atrial natriuretic peptide (ANP) characteristics in Type 2 diabetes mellitus (DM). Therefore, plasma immunoreactive ANP…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  5. 5
    The diabetic patient with hypertension

    The diabetic patient with hypertension by Leese, G. P., Savage, M. W., Chattington, P. D., Vora, J. P.

    Published in Postgraduate medical journal (01-05-1996)
    “…Hypertension and diabetes co-exist more commonly than would be expected from their individual prevalences. Elevated blood pressure is most commonly due to…”
    Get full text
    Journal Article Book Review
    Save to List
    Saved in:
  6. 6
    Partial hypopituitarism and Langerhans cell histiocytosis

    Partial hypopituitarism and Langerhans cell histiocytosis by Balaguruswamy, S, Chattington, P D

    Published in BMJ Case Reports (2011)
    “…A case of multisystem Langerhans cell histiocytosis with pituitary involvement nearly 20 years after initial presentation. A 48-year-old man had histiocytosis…”
    Get full text
    Report
    Save to List
    Saved in:
  7. 7
    Treatment of Hypertension in Diabetes

    Treatment of Hypertension in Diabetes by Cooper Mark, Jerums George, Chattington Paula

    “…Patients with type I and II diabetes mellitus represent a population at high risk of the cardiovascular, cerebrovascular and renal effects of hypertension…”
    Get full text
    Journal Article
    Save to List
    Saved in:

Search Tools: